Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement

Abstract

Most early SSc but only a few UCTD patients progress to definite SSc within a short-term follow-up. Measurement of circulating markers of T-cell and fibroblast activation might serve to identify early SSc patients who are more likely to develop features of definite SSc.